These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1623033)

  • 1. Omnipaque (iohexol).
    Claussen D
    Gastroenterol Nurs; 1992 Jun; 14(6):307-9. PubMed ID: 1623033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.
    Katayama H; Yamaguchi K; Kozuka T; Takashima T; Seez P; Matsuura K
    Radiology; 1990 Jun; 175(3):621-8. PubMed ID: 2343107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.
    Hill JA; Winniford M; Cohen MB; Van Fossen DB; Murphy MJ; Halpern EF; Ludbrook PA; Wexler L; Rudnick MR; Goldfarb S
    Am J Cardiol; 1993 Oct; 72(11):770-5. PubMed ID: 8213508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of a nonionic contrast medium (Omnipaque 350) in hysterosalpingography. A comparison with ionic contrast media].
    Innocenti P; Pandimiglio AM; Nicolucci A; Nori Bufalini G
    Radiol Med; 1989 Apr; 77(4):395-8. PubMed ID: 2727342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxicity of low-osmolar nonionic and high-osmolar ionic contrast media to dog gallbladder epithelial cells.
    Ju YM; Kim MH; Lee SK; Seo DW; Min YI; Kim JY
    Gastrointest Endosc; 2002 Mar; 55(3):382-6. PubMed ID: 11868013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective survey of delayed adverse reactions to ionic and nonionic contrast media.
    Yamaguchi K; Takanashi I; Kanauchi T; Hoshi T; Kubota H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1565-70. PubMed ID: 1465338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of drug eruption due to iohexol (Omnipaque)].
    Akiyama M; Iijima M; Fujisawa R
    Nihon Hifuka Gakkai Zasshi; 1990 Sep; 100(10):1057-60. PubMed ID: 1702479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of the nonionic contrast medium omnipaque in coronary angiography.
    Levorstad K; Vatne K; Brodahl U; Laake B; Simonsen S; Aakhus T
    Cardiovasc Intervent Radiol; 1989; 12(2):98-100. PubMed ID: 2500247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents.
    Wolf GL; Mishkin MM; Roux SG; Halpern EF; Gottlieb J; Zimmerman J; Gillen J; Thellman C
    Invest Radiol; 1991 May; 26(5):404-10. PubMed ID: 2055736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of disseminated intravascular coagulation caused by the nonionic contrast medium iohexol.
    Shigyo M; Tsukamoto T; Yanase M; Kumamoto Y; Aoki M; Katsumata K
    J Urol; 1995 Jun; 153(6):1901-3. PubMed ID: 7752347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thrombosis during coronary angioplasty with low osmolality contrast media.
    Esplugas E; Cequier A; Jara F; Mauri J; Soler T; Sala J; Sabate X
    Am J Cardiol; 1991 Oct; 68(10):1020-4. PubMed ID: 1927914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of a new non-ionic contrast medium--iohexol (Omnipaque)--in patients sensitive to ionic contrast medium].
    Fuse H; Miyazaki K; Nakasima T; Fujita Y
    Hinyokika Kiyo; 1989 Feb; 35(2):371-5. PubMed ID: 2735246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects.
    Wolf GL; Arenson RL; Cross AP
    AJR Am J Roentgenol; 1989 May; 152(5):939-44. PubMed ID: 2495706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed adverse reactions to nonionic monomeric contrast-enhanced media.
    Yasuda R; Munechika H
    Invest Radiol; 1998 Jan; 33(1):1-5. PubMed ID: 9438503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative trial of Omnipaque 350 (iohexol) and Telebrix 350 (sodium-meglumine-ioxithalamate) in left ventriculography and coronary arteriography.
    Jorgova J; Sedney MI; van der Wall EE; van Benthem A; Buis B
    Eur J Radiol; 1992; 15(1):75-82. PubMed ID: 1396796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of patient reactions and diagnostic quality for hysterosalpingography using ionic and nonionic contrast media.
    Chen MY; Zagoria RJ; Fayez JA; Ott DJ; Van Swearingen FL
    Acad Radiol; 1995 Feb; 2(2):123-7. PubMed ID: 9419535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium.
    Rydberg J; Charles J; Aspelin P
    Acta Radiol; 1998 May; 39(3):219-22. PubMed ID: 9571932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.